Retinal Non-Perfusion in Proliferative Diabetic Retinopathy Before and After Panretinal Photocoagulation Assessed by Wide Field OCT Angiography.
暂无分享,去创建一个
P. Rosenfeld | W. Feuer | G. Gregori | Hasenin Al-khersan | Yingying Shi | J. Russell | C. Lyu | Jonathan F. Russell | John W. Hinkle | K. Fan | N. L. Scott | N. Scott | Giovanni Gregori
[1] H. Flynn,et al. PATIENTS PRESENTING EMERGENTLY WITH PROLIFERATIVE DIABETIC RETINOPATHY: Follow-up and Factors Associated With Compliance. , 2020, Retina.
[2] A. Erginay,et al. Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor. , 2019, Ophthalmology.
[3] Giovanni Gregori,et al. Distribution of Diabetic Neovascularization on Ultra-Widefield Fluorescein Angiography and on Simulated Widefield OCT Angiography. , 2019, American journal of ophthalmology.
[4] Simon S. Gao,et al. Signal Strength Reduction Effects in OCT Angiography. , 2019, Ophthalmology. Retina.
[5] Daniel L. Chao,et al. OCT Angiography Biomarkers for Predicting Visual Outcomes after Ranibizumab Treatment for Diabetic Macular Edema. , 2019, Ophthalmology. Retina.
[6] C. Wykoff,et al. Longitudinal Retinal Perfusion Status in Eyes with Diabetic Macular Edema Receiving Intravitreal Aflibercept or Laser in VISTA Study. , 2019, Ophthalmology.
[7] Katherine E. Talcott,et al. Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: Outcomes from the Randomized RECOVERY Trial. , 2019, Ophthalmology. Retina.
[8] Reza Mirshahi,et al. Effects of panretinal photocoagulation on retinal vasculature and foveal avascular zone in diabetic retinopathy using optical coherence tomography angiography: A pilot study , 2019, Journal of current ophthalmology.
[9] Eric M. Moult,et al. Controlling for Artifacts in Widefield Optical Coherence Tomography Angiography Measurements of Non-Perfusion Area , 2019, Scientific Reports.
[10] J. Duker,et al. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy , 2019, International Ophthalmology.
[11] R. Linsenmeier,et al. IMPROVED MACULAR CAPILLARY FLOW ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY AFTER PANRETINAL PHOTOCOAGULATION FOR PROLIFERATIVE DIABETIC RETINOPATHY. , 2019, American journal of ophthalmology.
[12] E. Souied,et al. Optical Coherence Tomography Angiography Quantitative Assessment of Exercise-Induced Variations in Retinal Vascular Plexa of Healthy Subjects. , 2019, Investigative ophthalmology & visual science.
[13] P. Rosenfeld,et al. Longitudinal Wide-Field Swept-Source OCT Angiography of Neovascularization in Proliferative Diabetic Retinopathy after Panretinal Photocoagulation. , 2019, Ophthalmology. Retina.
[14] M. V. Cicinelli,et al. Panretinal Photocoagulation Does Not Change Macular Perfusion in Eyes With Proliferative Diabetic Retinopathy. , 2019, Ophthalmic surgery, lasers & imaging retina.
[15] C. Regillo,et al. Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor. , 2019, Ophthalmology.
[16] Adnan Tufail,et al. COMPARING FUNDUS FLUORESCEIN ANGIOGRAPHY AND SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN THE EVALUATION OF DIABETIC MACULAR PERFUSION , 2018, Retina.
[17] A. Yoshida,et al. Retinal blood flow reduction after panretinal photocoagulation in Type 2 diabetes mellitus: Doppler optical coherence tomography flowmeter pilot study , 2018, PloS one.
[18] Jennifer K. Sun,et al. Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial , 2018, JAMA ophthalmology.
[19] C. Wykoff,et al. Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion: Three-Year Randomized DAVE Trial. , 2018, Ophthalmology.
[20] S. Sivaprasad,et al. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study). , 2018, Ophthalmology.
[21] Bianca S. Gerendas,et al. Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema: A Subanalysis of the RESTORE (Extension) Study , 2018, JAMA ophthalmology.
[22] Q. Nguyen,et al. Diurnal variation of choriocapillaris vessel flow density in normal subjects measured using optical coherence tomography angiography , 2016, International Journal of Retina and Vitreous.
[23] K. Suzuma,et al. Evaluation of retinal blood flow before and after panretinal photocoagulation using pattern scan laser for diabetic retinopathy , 2017, Current eye research.
[24] S. Srinivas,et al. Pilot study of Doppler optical coherence tomography of retinal blood flow following laser photocoagulation in poorly controlled diabetic patients. , 2013, Investigative ophthalmology & visual science.
[25] B. Ghosh,et al. Ischemic maculopathy following intravitreal bevacizumab for refractory diabetic macular edema , 2011, International Ophthalmology.
[26] Ann L. Albright,et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. , 2010, JAMA.
[27] T. Peto,et al. MACULAR PERFUSION DETERMINED BY FUNDUS FLUORESCEIN ANGIOGRAPHY AT THE 4-MONTH TIME POINT IN A PROSPECTIVE RANDOMIZED TRIAL OF INTRAVITREAL BEVACIZUMAB OR LASER THERAPY IN THE MANAGEMENT OF DIABETIC MACULAR EDEMA (BOLT STUDY): Report 1 , 2010, Retina.
[28] Hyoung Jun Koh,et al. Enlargement of the foveal avascular zone in diabetic retinopathy after adjunctive intravitreal bevacizumab (avastin) with pars plana vitrectomy. , 2009, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[29] C. Tinley,et al. Routine, single session, indirect laser for proliferative diabetic retinopathy , 2009, Eye.
[30] Nathan Congdon,et al. The Prevalence of Diabetic Retinopathy in the United States , 2002 .
[31] B. Petrig,et al. Retinal blood flow regulation and the clinical response to panretinal photocoagulation in proliferative diabetic retinopathy. , 1989, Ophthalmology.
[32] B. Petrig,et al. Effect of panretinal photocoagulation on retinal blood flow in proliferative diabetic retinopathy. , 1986, Ophthalmology.
[33] H. Schatz,et al. Visual loss following panretinal photocoagulation for proliferative diabetic retinopathy. , 1985, Ophthalmology.
[34] S. Hayreh,et al. Experimental occlusion of the central artery of the retina. I. Ophthalmoscopic and fluorescein fundus angiographic studies. , 1980, The British journal of ophthalmology.
[35] Curtis L. Meinert,et al. Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. , 1978, Ophthalmology.